Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2025Journal of Clinical InvestigationOpen Access

Plasminogen Activator Inhibitor-1 promotes aortic aging-like pathophysiology in humans and mice

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAlireza KhoddamAKAnthony KalousdianMEMesut Eren

Discussion

Loading...

Member takes

Overview

Mouse model analysis shows PAI-1 promotes cardiovascular aging and related pathologies in humans, suggesting intervention potential.

Key Points

  • Reduction in PAI-1 in mice was linked to 20% longer lifespan and improved cardiovascular function despite stress.
  • Mice with PAI-1 overexpression showed accelerated cardiovascular aging evidenced by worsened systolic hypertension.
  • Single cell transcriptomics indicated a protective mechanism in aortas of Serpine1TA700/+ mice through extracellular matrix regulation.
  • Inhibition of PAI-1 reversed aging-related vascular changes and normalized systolic blood pressure in stressed mice.

Cite This Study

Khoddam et al. (2025) studied this question.

synapsesocial.com/papers/68dd91d5fe798ba2fc498f84https://doi.org/10.1172/jci196714
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract Fri020: Plasminogen Activator Inhibitor-1 Governs Vascular Aging2025
  2. 2Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis2017 · 94 citations
  3. 3Plasminogen Activator Inhibitor-1 Antagonist TM5441 Attenuates N <sup>ω</sup> -Nitro- <scp>l</scp> -Arginine Methyl Ester–Induced Hypertension and Vascular Senescence2013 · 133 citations
  4. 4Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture2009 · 73 citations
  5. 5Roles of plasminogen activator inhibitor-1 in aging-related muscle and bone loss in mice2025 · 1 citations